Videos

#Data #Data security #Database #Thermo Fisher Scientific

Listicle: Three data problems solved by a connected lab

In this listicle, Thermo Fisher Scientific outlines three problems solved by the Thermo Fisher Connect Platform Team Edition and below, they expand to five reasons why companies should consider this platform.  How do you secure your data? How do you share instruments? The Thermo Fisher Connect Platform Team… Read More

#Listicles #Videos

#Drug development #High throughput screening #Immunology / Virology & Vaccines #IVT #mRNA #RNA #Thermo Fisher Scientific

Listicle: Five tips on scaling up IVT for mRNA production

In this listicle, Thermo Fisher Scientific outlines five measures to help you ensure consistency in your workflow and produce reproducible, high-quality batches of IVT mRNA at scale. The success of messenger RNA (mRNA) vaccines in combatting the global SARS-CoV-2 crisis brings a new era of vaccine development. Read More

#Listicles #Videos

Vodcast: Avacta Group Open Day 2022

Clinical stage oncology company Avacta Group has moved its Therapeutics division to a new headquarters at Scale Space in Imperial College’s White City Campus, London. DDW Multimedia Editor Megan Thomas attended the open day to learn more about the company’s intentions. In this video, she speaks to Neil… Read More

#Videos

#Automation / robotics #Biologics #Process analytical technology

Listicle: Driving production in biologics with automation 

Drug development technology has evolved rapidly in recent years, and with the industry advancement comes an increased capability of producing high-quality targeted large molecule drugs such as biologics and biosimilars. The significance of biologics is far-reaching, including treatment of rheumatologic diseases, cancer, diabetes and anaemia. The range of… Read More

#Editor's Choice #Listicles #Videos

#Analysis #Biotechnology #Health #Life sciences

Listicle: Lithuania’s biotechnology growth strategy

Lithuania is dedicating time and resources establishing itself as a life science and biotechnology hub of excellence. DDW’s Megan Thomas analyses four pillars of Lithuania’s growth strategy, which involves ensuring female scientists take leading roles in industry, focusing on investment, developing a strong talent pool as well establishing itself as… Read More

#Editor's Choice #Exclusive Content #Listicles #News #Videos

#Drug development

Developing pain medication with fewer side effects 

Dr. Ken Ng, a professor at the University of Windsor and adjunct professor at the University of Calgary (UCalgary), and Sam Carr, a PhD student from UCalgary, have been working with Dr. Peter Facchini’s group at UCalgary to better understand how natural opiates are produced. The team has narrowed their focus on one… Read More

#News #Videos

#Biology #Drug development #Therapeutics

Closing drug development gaps with new clinical prediction AI 

Quris, an artificial intelligence (AI) company in the pharmaceutical industry, has launched a clinical prediction AI platform to predict which drug candidates will safely work in humans. This will improve efficacy and cut drug development costs.   What do they do?  Quris uses AI-powered miniaturised “patients-on-a-chip” to avoid… Read More

#News #Videos

#Biotechnology #Pharma #Pharmacovigilance #Regulatory

Listicle: Experts on the differences between FDA and EMA regulations

Biotechs involved in drug discovery have to navigate increasingly complex regulatory environments across borders. Experienced experts and non-executive advisors to Arriello, Eric Caugant, Principal Consultant at Pharmacovigilance Systems Consulting & Board advisor to Arriello, and Judi Sills, JM Sills Consulting & Board advisor to Arriello, highlight the main differences between US… Read More

#Listicles #News #Sponsored Content #Videos

#Assays #Biosciences #Protein chemistry / Proteomics

Protein-protein Interactions Using NanoBRET Technology

In this video, Dr Gary Allenby, CEO Aurelia Bioscience, describes a scientific poster on ‘Protein-protein Interactions Using NanoBRET Technology’. Historically, only solution-based assays were used to screen compounds in PPI, but a more physiological approach is to examine the interaction in living cells. However, there are very few… Read More

#News #Trending News #Videos

#Bioscience #Screening

Micro Tissues on Electrospun Scaffolds

In this video, Dr Gary Allenby, CEO Aurelia Bioscience, describes a scientific poster on ‘Magnetic Electrospun Micro-fibre Scaffold Assemblies: Examples of their use for 3-Dimensional Cell-Based Screening Applications’. How the technology works: Aurelia Bioscience has developed a 3-D micro-tissue system from electrospun material that can be used in… Read More

#News #Videos

The gel-free, blot-free, hands-free reinvention of western blotting

Aurelia Bioscience, a Nottingham, UK based pre-clinical Contract Research Organisation (CRO) has produced a video to explain the functioning of WES and JESS – two highly reproducible, capillary based, automated western blot instruments from ProteinSimple: Whilst traditional western blotting typically runs 10-20 samples in three to five hours… Read More

#Videos

#Assay #Bioscience #Drug development #Kinetics #Video

Re-energise your kinase discovery programme

Using Promega’s NanoBRET technology, scientists at Aurelia Bioscience have implemented intracellular kinase assays designed to study the interaction of compounds on kinase targets in intact living cells. Advantages of this technique include examination of compound binding to target kinases at physiological ATP concentrations, expression of full-length kinase target… Read More

#Videos

#Alzheimer's #Biologics

C. elegans: a natural model for developing therapies to slow ageing

Ageing is a complex and heterogeneous process and is best studied using natural models of ageing in whole organisms and large test populations. C. elegans is a proven model in many fields of biology including ageing, where major breakthroughs have occurred by identifying mutants and interventions that increase… Read More

#News #Videos